ProQR Therapeutics (PRQR) Long-Term Investments (2021 - 2022)
ProQR Therapeutics (PRQR) has disclosed Long-Term Investments for 2 consecutive years, with $633573.6 as the latest value for Q4 2022.
- Quarterly Long-Term Investments rose 6822.96% to $633573.6 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $633573.6 through Dec 2022, up 6822.96% year-over-year, with the annual reading at $633573.6 for FY2022, 6592.32% up from the prior year.
- Long-Term Investments hit $633573.6 in Q4 2022 for ProQR Therapeutics, up from $9151.8 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $633573.6 in Q4 2022 to a low of $9151.8 in Q4 2021.